Nanotechnology RSS feeds

ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN


copyright-Nanovip 2008

NANO FACTS

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide
nanotechnology companies | nanotechnology info Sheet Paper 100,000 nm wide

LATEST MEMBERS

  • MVSathy
  • martim
  • jameskahelin
  • lisa richards
  • tokmik
  • PamelSMIT

WHO'S ONLINE

There are currently 0 users and 4 guests online.

  Valid XHTML 1.0 Transitional

Button for your site

Stemedica Cell Technologies, Inc.


Address: 5375 Mira Sorrento Pl, Suite 100
Zip: 92121

Visit this link

Phone :
858-658-0910

Fax :
858-658-0986

These accomplishments are driven by a world class team of prominent scientists, leading clinicians, and executives from successful nutritional, medical and pharmaceutical businesses. The members of the team are located in Centers of Excellence in San Diego, CA, Palo Alto, CA, and Eastern Europe and are directed toward solving the problems associated with this new generation of medicine.

Stemedica Cell Technologies is supported by both individual and institutional funding. Our experienced management team has been responsible for launching several successful companies and the members of our Founders and Scientific Advisory Board have been involved in developing and bringing to market "industry first" medical device, biotech, pharmaceutical and nutraceutical products. We are committed to, and capable of, delivering sustained growth and superior value to our shareholders.

Stemedica is becoming one of the undisputed leaders in engineering the new frontier of adult stem cell methodologies, technologies, therapies and treatment protocols.

» | Edit this entry
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page